Completed
Whey Protein Supplementation in HIV-Infected Children: A Pilot Study
Learn MoreReporting
Disentangling medicinal and non-medicinal cannabis use among people living with HIV: Feasibility of a smartphone-based assessment
Learn MoreEnrolling
Using a novel assay to detect syphilis infection early in asymptomatic men who have sex with men (MSM) undergoing STI screening
Learn MoreEnrolling
Association of vitamin D insufficiency with non-alcoholic fatty liver disease in HIV mono-infected patients
Learn MoreCompleted
Acceptability and implications of the rapid hepatitis C virus screening test among provincial prison inmates in Quebec: A pilot study
Learn MoreCompleted
Anemia Among HIV-infected Children Receiving Zidovudine: Identification of Markers of Erythropoietin Deficiency and Likelihood of Response to Exogenous Erythropoietin
Learn MoreCompleted
Active Immunization of Patients with HIV Infection: The Study of the Effect of VaxSyn on Progression of Immunodeficiency (gp160): Trial results
Learn MoreReporting
Camu Camu effects on circulating LPS and systemic immune activation in ART-treated participants
Learn MoreEnrolling
Vedolizumab treatment in antiretroviral drug treated chronic HIV infection, followed by analytical treatment interruption (HIV-ART-vedolizumab-ATI)
Learn More
CTN Trials have been approved by the Community Advisory Committee of the Canadian HIV Trials Network and the Network’s Scientific Review Committee, or other national peer-review panels such as those at the Canadian Institutes of Health Research and the U.S. National Institutes of Health. CTNPT studies are small-scale investigations designed to determine the feasibility of research concepts, and do not all go through the regular CTN clinical trial review process. For information on the benefits and risks of participating in HIV clinical trials, call CATIE toll-free at 1-800-263-1638.
